Compile Data Set for Download or QSAR
Report error Found 56 Enz. Inhib. hit(s) with all data for entry = 743
TargetMonoglyceride lipase(Human)
Abide Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 38015BDBM38015(US10093635, Example 54 | 2-(2-fluoro-6-((4-(((1,1,...)
Affinity DataIC50: 550nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

TargetMonoglyceride lipase(Human)
Abide Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 38014BDBM38014(US10093635, Example 53 | 1,1,1,3,3,3-hexafluoropro...)
Affinity DataIC50: 5.50E+3nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

TargetMonoglyceride lipase(Human)
Abide Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 38016BDBM38016(US10093635, Example 55 | 1,1,1,3,3,3-hexafluoropro...)
Affinity DataIC50: 5.50E+3nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

TargetMonoglyceride lipase(Human)
Abide Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 38018BDBM38018(US10093635, Example 56 | 4-(2-chloro-6-((4- (((1,1...)
Affinity DataIC50: 5.50E+3nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

TargetMonoglyceride lipase(Human)
Abide Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 37951BDBM37951(US10093635, Example 1 | 1,1,1,3,3,3-Hexafluoroprop...)
Affinity DataIC50: 5.50E+3nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

TargetMonoglyceride lipase(Human)
Abide Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 37954BDBM37954(US10093635, Example 2 | 1,1,1,3,3,3-Hexafluoroprop...)
Affinity DataIC50: 5.50E+3nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

TargetMonoglyceride lipase(Human)
Abide Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 37955BDBM37955(US10093635, Example 3 | 4-(2-((4-(((1,1,1,3,3,3-He...)
Affinity DataIC50: 5.50E+3nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

TargetMonoglyceride lipase(Human)
Abide Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 37956BDBM37956(US10093635, Example 4 | 4-(5-Chloro-2-((4-(((1,1,1...)
Affinity DataIC50: 5.50E+3nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

TargetMonoglyceride lipase(Human)
Abide Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 37967BDBM37967(US10093635, Example 13 | 2-(5-Chloro-2-((4-(((1,1,...)
Affinity DataIC50: 5.50E+3nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

TargetMonoglyceride lipase(Human)
Abide Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 37970BDBM37970(US10093635, Example 14 | 2-(2-((4-(((1,1,1,3,3,3-H...)
Affinity DataIC50: 5.50E+3nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

TargetMonoglyceride lipase(Human)
Abide Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 37972BDBM37972(US10093635, Example 15 | 5-(2-((4-(((1,1,1,3,3,3-H...)
Affinity DataIC50: 5.50E+3nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

TargetMonoglyceride lipase(Human)
Abide Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 37973BDBM37973(US10093635, Example 16 | 1-(2-((4-(((1,1,1,3,3,3-H...)
Affinity DataIC50: 5.50E+3nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

TargetMonoglyceride lipase(Human)
Abide Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 37974BDBM37974(US10093635, Example 17 | 2-(3-((4-(((1,1,1,3,3,3-h...)
Affinity DataIC50: 5.50E+3nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

TargetMonoglyceride lipase(Human)
Abide Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 37975BDBM37975(US10093635, Example 18 | 4-(2-((4-(((1,1,1,3,3,3-h...)
Affinity DataIC50: 5.50E+3nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

TargetMonoglyceride lipase(Human)
Abide Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 37976BDBM37976(US10093635, Example 19 | 1-(3-((4-(((1,1,1,3,3,3-h...)
Affinity DataIC50: 5.50E+3nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

TargetMonoglyceride lipase(Human)
Abide Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 37978BDBM37978(US10093635, Example 20 | 1,1,1,3,3,3-hexafluoropro...)
Affinity DataIC50: 5.50E+3nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

TargetMonoglyceride lipase(Human)
Abide Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 37957BDBM37957(US10093635, Example 5 | 1,1,1,3,3,3-Hexafluoroprop...)
Affinity DataIC50: 5.50E+3nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

TargetMonoglyceride lipase(Human)
Abide Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 37960BDBM37960(US10093635, Example 6 | 1,1,1,3,3,3-Hexafluoroprop...)
Affinity DataIC50: 5.50E+3nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

TargetMonoglyceride lipase(Human)
Abide Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 37961BDBM37961(US10093635, Example 7 | 1,1,1,3,3,3-Hexafluoroprop...)
Affinity DataIC50: 5.50E+3nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

TargetMonoglyceride lipase(Human)
Abide Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 37962BDBM37962(US10093635, Example 8 | 1,1,1,3,3,3-Hexafluoroprop...)
Affinity DataIC50: 5.50E+3nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

TargetMonoglyceride lipase(Human)
Abide Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 37963BDBM37963(US10093635, Example 9 | 2-(2-((2-((4-(((1,1,1,3,3,...)
Affinity DataIC50: 5.50E+3nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

TargetMonoglyceride lipase(Human)
Abide Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 37964BDBM37964(US10093635, Example 10 | 2-(2-((4-Chloro-2-((4-(((...)
Affinity DataIC50: 5.50E+3nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

TargetMonoglyceride lipase(Human)
Abide Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 37965BDBM37965(US10093635, Example 11 | 2-(2-((2-Fluoro-6-((4-(((...)
Affinity DataIC50: 5.50E+3nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

TargetMonoglyceride lipase(Human)
Abide Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 37966BDBM37966(US10093635, Example 12 | N-(2-((5-Chloro-2-((4-(((...)
Affinity DataIC50: 5.50E+3nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

TargetMonoglyceride lipase(Human)
Abide Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 37987BDBM37987(US10093635, Example 29 | 1-((2-fluoro-6-((4-(((1,1...)
Affinity DataIC50: 5.50E+3nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

TargetMonoglyceride lipase(Human)
Abide Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 37988BDBM37988(US10093635, Example 30 | 1-((2-((4-(((1,1,1,3,3,3-...)
Affinity DataIC50: 5.50E+3nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

TargetMonoglyceride lipase(Human)
Abide Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 37990BDBM37990(US10093635, Example 31 | 1,1,1,3,3,3-hexafluoropro...)
Affinity DataIC50: 5.50E+3nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

TargetMonoglyceride lipase(Human)
Abide Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 37991BDBM37991(US10093635, Example 32 | 1-((2-fluoro-6-((4-(((1,1...)
Affinity DataIC50: 5.50E+3nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

TargetMonoglyceride lipase(Human)
Abide Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 37992BDBM37992(US10093635, Example 33 | 1-((2,3-difluoro-6-((4-((...)
Affinity DataIC50: 5.50E+3nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

TargetMonoglyceride lipase(Human)
Abide Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 37993BDBM37993(US10093635, Example 34 | 1-((4,5-difluoro-2-((4-((...)
Affinity DataIC50: 5.50E+3nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

TargetMonoglyceride lipase(Human)
Abide Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 37994BDBM37994(US10093635, Example 35 | 1-((5-cyano-2-((4-(((1,1,...)
Affinity DataIC50: 5.50E+3nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

TargetMonoglyceride lipase(Human)
Abide Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 37995BDBM37995(US10093635, Example 36 | 1-((2-cyano-6-((4-(((1,1,...)
Affinity DataIC50: 5.50E+3nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

TargetMonoglyceride lipase(Human)
Abide Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 37979BDBM37979(US10093635, Example 21 | 1,1,1,3,3,3-hexafluoropro...)
Affinity DataIC50: 5.50E+3nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

TargetMonoglyceride lipase(Human)
Abide Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 37980BDBM37980(US10093635, Example 22 | 1-(2-((4-(((1,1,1,3,3,3-H...)
Affinity DataIC50: 5.50E+3nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

TargetMonoglyceride lipase(Human)
Abide Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 37981BDBM37981(US10093635, Example 23 | 1-((2-Chloro-6-((4-(((1,1...)
Affinity DataIC50: 5.50E+3nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

TargetMonoglyceride lipase(Human)
Abide Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 37982BDBM37982(US10093635, Example 24 | 4-(2-Fluoro-6-((4-(((1,1,...)
Affinity DataIC50: 5.50E+3nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

TargetMonoglyceride lipase(Human)
Abide Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 37983BDBM37983(US10093635, Example 25 | 4-(2-Fluoro-6-((4-(((1,1,...)
Affinity DataIC50: 5.50E+3nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

TargetMonoglyceride lipase(Human)
Abide Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 37984BDBM37984(US10093635, Example 26 | 1-((2-Cyano-4-fluoro-6-((...)
Affinity DataIC50: 5.50E+3nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

TargetMonoglyceride lipase(Human)
Abide Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 37985BDBM37985(US10093635, Example 27 | 1-((2-((4-(((1,1,1,3,3,3-...)
Affinity DataIC50: 5.50E+3nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

TargetMonoglyceride lipase(Human)
Abide Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 37986BDBM37986(US10093635, Example 28 | 1-((3-((4-(((1,1,1,3,3,3-...)
Affinity DataIC50: 5.50E+3nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

TargetMonoglyceride lipase(Human)
Abide Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 38005BDBM38005(US10093635, Example 45 | (1S,3R)-3-(2-((4-(((1,1,1...)
Affinity DataIC50: 5.50E+3nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

TargetMonoglyceride lipase(Human)
Abide Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 38006BDBM38006(US10093635, Example 46 | (1R,3R)-3-(2-((4-(((1,1,1...)
Affinity DataIC50: 5.50E+3nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

TargetMonoglyceride lipase(Human)
Abide Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 38007BDBM38007(US10093635, Example 47 | (1r,3r)-3-(2-((4-(((1,1,1...)
Affinity DataIC50: 5.50E+3nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

TargetMonoglyceride lipase(Human)
Abide Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 38009BDBM38009(US10093635, Example 48 | 4-(3-((4-(((1,1,1,3,3,3-h...)
Affinity DataIC50: 5.50E+3nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

TargetMonoglyceride lipase(Human)
Abide Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 38010BDBM38010(US10093635, Example 49 | 2-(2-chloro-6-((4-(((1,1,...)
Affinity DataIC50: 5.50E+3nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

TargetMonoglyceride lipase(Human)
Abide Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 38011BDBM38011(US10093635, Example 50 | 1,1,1,3,3,3-hexafluoropro...)
Affinity DataIC50: 5.50E+3nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

TargetMonoglyceride lipase(Human)
Abide Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 38012BDBM38012(US10093635, Example 51 | 1,1,1,3,3,3-hexafluoropro...)
Affinity DataIC50: 5.50E+3nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

TargetMonoglyceride lipase(Human)
Abide Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 38013BDBM38013(US10093635, Example 52 | 1,1,1,3,3,3-hexafluoropro...)
Affinity DataIC50: 5.50E+3nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

TargetMonoglyceride lipase(Human)
Abide Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 37996BDBM37996(US10093635, Example 37 | 1-((2,3-difluoro-6-((4-((...)
Affinity DataIC50: 5.50E+3nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

TargetMonoglyceride lipase(Human)
Abide Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 37997BDBM37997(US10093635, Example 38 | 1-((3-fluoro-6-((4-(((1,1...)
Affinity DataIC50: 5.50E+3nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

Displayed 1 to 50 (of 56 total ) | Next | Last >>
Jump to: